A prehospital protocol for transfusion of low‐titer O‐positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn
Transfusion · 2025
DOI: 10.1111/trf.18184 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Transfusion, 2025. Verfasst von Kelsey Wilhelm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Harbor-UCLA Medical Center & The Lundquist Institute, Torrance, California, USA. Hauptthemen laut MEDLINE: Shock, Hemorrhagic, Blood Transfusion, Emergency Medical Services, Erythroblastosis, Fetal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The Los Angeles Development and Rapid Operationalization of Prehospital Blood (LA‐DROP) pilot will protocolize prehospital administration of low titer O‐positive whole blood (LTO + WB) to patients with hemorrhagic shock in Los Angeles County (LAC). We sought to quantify the risk of death from hemolytic disease of the fetus and newborn (HDFN) associated with RhD‐negative alloimmunization in females of childbearing potential (FCPs) as a result of LA‐DROP. Study Design and Methods Retrospective data from LAC EMS databases were used in combination with estimates from published literature to assign probability distributions to each event in the sequence required for a transfusion of LTO + WB to result in a death from HDFN. Markov chain Monte Carlo simulation was used to derive risk estimates.
Results
We estimated that the proposed prehospital transfusion strategy would result on average in one death from HDFN for every 10,000 transfusions in the overall population (95% confidence interval [CI] 6000–25,000) and for every 1800 transfusions in FCPs (95% CI 1000–4300). Based on the projected annual volume of transfusions under LA‐DROP, this would result in one death due to HDFN approximately every 26 years (95% CI 15–64).
Discussion
The estimated per‐transfusion risk of HDFN is similar to previously published work from other populations. The estimated frequency of deaths from HDFN associated with LA‐DROP is lower than some previously published calculations, likely because of narrower eligibility criteria for transfusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Harbor-UCLA Medical Center & The Lundquist Institute, Torrance, California, USA.
- David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- City of Compton Fire Department, Compton, California, USA.
- Department of Pathology and Laboratory Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
- Department of Surgery and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Kelsey Wilhelm, Caroline Lauer, Rachel Rangwala, Philip C Spinella
Zitieren
APA
Wilhelm, K., Lauer, C., Rangwala, R., Zadeh, T., Spinella, P. C., & Tolles, J. (2025). A prehospital protocol for transfusion of low‐titer O‐positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn. Transfusion. https://doi.org/10.1111/trf.18184
Vancouver
Wilhelm K, Lauer C, Rangwala R, Zadeh T, Spinella PC, Tolles J. A prehospital protocol for transfusion of low‐titer O‐positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn. Transfusion. 2025. doi:10.1111/trf.18184
BibTeX
@article{Wilhelm2025,
author = {Wilhelm, Kelsey and Lauer, Caroline and Rangwala, Rachel and Zadeh, Tanin and Spinella, Philip C and Tolles, Juliana},
title = {A prehospital protocol for transfusion of low‐titer O‐positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18184}
}
EUVIMED